MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Pulse Biosciences Cash Conversion Cycle 2011-2025 | PLSE
Annual Cash Conversion Cycle Pulse Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 36.5 | 119 | -1.34 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 119 | -1.34 K | -396 |
Quarterly Cash Conversion Cycle Pulse Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -918 | - | - | - | - | - | - | - | - | - | - | - | 25.3 | 342 | 356 | - | 96.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 356 | -918 | -19.7 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.65 | 1.05 % | $ 1.14 B |  USA |
 |
Baxter International
BAX
|
262 | $ 19.49 | 1.72 % | $ 9.94 B | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 201.36 | 0.2 % | $ 57.9 B | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
266 | $ 4.6 | -1.46 % | $ 92.7 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
Harvard Bioscience
HBIO
|
208 | $ 0.73 | -0.96 % | $ 31 M | USA |
 |
Alcon
ALC
|
134 | $ 79.68 | 1.1 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
143 | $ 148.09 | -0.23 % | $ 3.61 B | USA |
 |
AtriCure
ATRC
|
185 | $ 41.89 | -1.17 % | $ 1.97 B | USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
2.97 | $ 4.77 | 0.42 % | $ 26.3 K | USA |
 |
iRhythm Technologies
IRTC
|
58.7 | $ 169.65 | 0.49 % | $ 5.29 B | USA |
 |
AngioDynamics
ANGO
|
124 | $ 13.24 | 0.78 % | $ 541 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 82.0 | -0.1 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 110.74 | 1.69 % | $ 5.36 B | USA |
 |
Repro Med Systems
KRMD
|
149 | $ 5.89 | 1.9 % | $ 269 M | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 82.06 | -1.71 % | $ 4.13 B | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 9.24 | - | $ 191 M | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.7 | $ 83.88 | -0.14 % | $ 1.88 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 137.07 | -0.92 % | $ 7.31 B | USA |
 |
Merit Medical Systems
MMSI
|
171 | $ 86.34 | -0.42 % | $ 5.03 B | USA |
 |
Intuitive Surgical
ISRG
|
208 | $ 557.84 | 2.86 % | $ 198 B | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.33 | -3.5 % | $ 23.8 M |  Israel |
 |
OraSure Technologies
OSUR
|
167 | $ 2.51 | 0.81 % | $ 187 M | USA |
 |
Milestone Scientific
MLSS
|
545 | $ 0.35 | -9.85 % | $ 27.9 M | USA |
 |
Nephros
NEPH
|
161 | $ 5.02 | - | $ 52.1 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
79.4 | $ 22.15 | 0.82 % | $ 3.81 B | USA |
 |
ResMed
RMD
|
167 | $ 254.83 | 0.98 % | $ 37.2 B | USA |
 |
Pro-Dex
PDEX
|
193 | $ 43.88 | 1.15 % | $ 144 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 23.95 | -0.75 % | $ 1.18 B | USA |
 |
STERIS plc
STE
|
112 | $ 253.14 | 0.49 % | $ 25 B | USA |
 |
Stereotaxis
STXS
|
212 | $ 2.37 | - | $ 191 M | USA |
 |
Predictive Oncology
POAI
|
-241 | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 160.0 | 1.66 % | $ 8.92 M | USA |
 |
Utah Medical Products
UTMD
|
280 | $ 58.1 | - | $ 211 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.6 | 0.22 % | $ 2.36 B | USA |
 |
Retractable Technologies
RVP
|
250 | $ 0.82 | -0.66 % | $ 24.5 M | USA |
 |
Teleflex Incorporated
TFX
|
183 | $ 128.08 | 1.11 % | $ 6 B | USA |
 |
West Pharmaceutical Services
WST
|
98.9 | $ 268.47 | 0.34 % | $ 19.6 B | USA |